Fatma Saricaoglu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Fatma Saricaoglu has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Seda Banu Akıncı
Division of Intensive Care, Department of Anesthesiology and Reanimation, Faculty of Medicine, Hacettepe University, Ankara, Türkiye
3 shared publications - Ulku Aypar
UFUK ÜNİVERSİTESİ, TIP FAKÜLTESİ
2 shared publications - Ahmet Mazhar Tokgozoglu
Department of Orthopaedics and Traumatology, Hacettepe University, Ankara, Türkiye
1 shared publication - Akin Cil
Department of Civil and Mechanical Engineering, University of Missouri-Kansas City, 5110 Rockhill Road, Kansas City, MO 64110, USA
1 shared publication Bahar Oc
1 shared publication- Banu Kilicaslan
Department of Anesthesiology and Reanimation, Faculty of Medicine, Hacettepe University, Ankara, Turkey
1 shared publication
Latest Publications
- Open Access
- 27 April 2026
- Published by Springer Nature in BMC Anesthesiology
- Vol. 26 (1)
Pericapsular nerve group with lateral femoral cutaneous nerve block vs. suprainguinal fascia iliaca block for analgesia in total hip arthroplasty: a prospective comparative study
To comparepostoperative analgesia, opioid consumption, and early motor function between suprainguinal fascia iliaca block (SFIB) and pericapsular nerve gro
- 27 April 2026
- Published by Springer Nature in BMC Anesthesiology
- Vol. 26 (1)
Open AccessPericapsular nerve group with lateral femoral cutaneous nerve block vs. suprainguinal fascia iliaca block for analgesia in total hip arthroplasty: a prospective comparative study
To comparepostoperative analgesia, opioid consumption, and early motor function between suprainguinal fascia iliaca block (SFIB) and pericapsular nerve gro
- Open Access
- 30 June 2025
- Published by Selcuk University in Genel Tıp Dergisi
- Vol. 35 (3) , 554-559
Postoperative Analgesia After Hand Surgery: A Controlled Comparison of Dexketoprofen Trometamol and Paracetamol
Aim: This prospective, randomized, double-blind study compared the efficacy and safety of dexketoprofen trometamol (DT) and paracetamol in managing postoperative pain for patients undergoing intravenous regional anesthesia (IVRA) during hand surgery. Methods: Sixty-six ASA I-II patients aged 18-70 were enrolled after exclusion criteria, including drug allergies, psychiatric disorders, Raynaud’s disease, and anticoagulant therapy. Patients were randomized into two groups: Group 1 received 25 mg DT, and Group 2 received 500 mg paracetamol for postoperative pain relief. At home postoperatively, pain intensity was assessed using the visual analog scale (VAS), and rescue analgesia was provided if needed. Patients recorded pain relief efficacy, satisfaction levels, side effects, and tablet consumption over 30 hours. Results: While both DT and paracetamol provided adequate postoperative pain relief, key differences were observed. Group 1 reported significantly higher analgesic efficacy (p = 0.001) and satisfaction levels (p = 0.003), with 75.8% of patients experiencing complete pain relief compared to 42.4% in Group 2. Moreover, postoperative morphine requirements were significantly lower in Group 1 (p = 0.04), highlighting its superior ability to manage pain while minimizing opioid use. VAS scores at various postoperative intervals showed no statistically significant differences between the two groups. However, Group 1 reached peak pain intensity at 6 hours postoperatively, while Group 2 peaked at 12 hours, suggesting DT's faster onset of action. Both groups demonstrated similar demographic and surgical characteristics, ensuring robust comparability. The frequency of side effects, such as nausea, vomiting, headache, and insomnia, was low and comparable between the groups (p > 0.05), underscoring the safety profiles of both drugs. Conclusions: DT offers superior postoperative pain control, reduced opioid reliance, and higher patient satisfaction compared to paracetamol following IVRA in ambulatory hand surgery. These findings support DT as a promising alternative to paracetamol in multimodal analgesia strategies. Additional studies are needed to confirm these findings and examine the mechanisms behind the differences in observed outcomes. The choice of analgesic should remain patient-specific, considering individual clinical conditions, contraindications, and preferences.
- 30 June 2025
- Published by Selcuk University in Genel Tıp Dergisi
- Vol. 35 (3) , 554-559
Open AccessPostoperative Analgesia After Hand Surgery: A Controlled Comparison of Dexketoprofen Trometamol and Paracetamol
Aim: This prospective, randomized, double-blind study compared the efficacy and safety of dexketoprofen trometamol (DT) and paracetamol in managing postoperative pain for patients undergoing intravenous regional anesthesia (IVRA) during hand surgery. Methods: Sixty-six ASA I-II patients aged 18-70 were enrolled after exclusion criteria, including drug allergies, psychiatric disorders, Raynaud’s disease, and anticoagulant therapy. Patients were randomized into two groups: Group 1 received 25 mg DT, and Group 2 received 500 mg paracetamol for postoperative pain relief. At home postoperatively, pain intensity was assessed using the visual analog scale (VAS), and rescue analgesia was provided if needed. Patients recorded pain relief efficacy, satisfaction levels, side effects, and tablet consumption over 30 hours. Results: While both DT and paracetamol provided adequate postoperative pain relief, key differences were observed. Group 1 reported significantly higher analgesic efficacy (p = 0.001) and satisfaction levels (p = 0.003), with 75.8% of patients experiencing complete pain relief compared to 42.4% in Group 2. Moreover, postoperative morphine requirements were significantly lower in Group 1 (p = 0.04), highlighting its superior ability to manage pain while minimizing opioid use. VAS scores at various postoperative intervals showed no statistically significant differences between the two groups. However, Group 1 reached peak pain intensity at 6 hours postoperatively, while Group 2 peaked at 12 hours, suggesting DT's faster onset of action. Both groups demonstrated similar demographic and surgical characteristics, ensuring robust comparability. The frequency of side effects, such as nausea, vomiting, headache, and insomnia, was low and comparable between the groups (p > 0.05), underscoring the safety profiles of both drugs. Conclusions: DT offers superior postoperative pain control, reduced opioid reliance, and higher patient satisfaction compared to paracetamol following IVRA in ambulatory hand surgery. These findings support DT as a promising alternative to paracetamol in multimodal analgesia strategies. Additional studies are needed to confirm these findings and examine the mechanisms behind the differences in observed outcomes. The choice of analgesic should remain patient-specific, considering individual clinical conditions, contraindications, and preferences.
- 2 May 2021
- Published by Springer Nature in Indian Journal of Surgery
- Vol. 84 (2) , 316-325
Remote Ischemic Conditioning Increases Organ Injury in Murine Sepsis: Experimental Research
- 2 May 2021
- Published by Springer Nature in Indian Journal of Surgery
- Vol. 84 (2) , 316-325
Remote Ischemic Conditioning Increases Organ Injury in Murine Sepsis: Experimental Research
- Open Access
- 1 January 2021
- Published by AVES YAYINCILIK A.Ş. in Acta Orthopaedica et Traumatologica Turcica
- Vol. 55 (1) , 53-56
Vancomycin prophylaxis for revision hip arthroplasty in penicillin and cephalosporin sensitive patients: Is dose adjustment necessary in accordance with blood loss and fluid replacement?
Objective: The aims of this study were (1) to investigate the changes in the serum concentration of prophylactically administrated vancomycin in the perioperative period of revision hip arthroplasty in penicillin/cephalosporin-allergic patients, (2) to assess whether the postoperative re-administration of vancomycin is needed, and (3) to determine the relationships of vancomycin serum concentration with blood loss, body weight, and fluid replacement in such patients. Methods: This study consisted of 29 patients (20 females, 9 males; mean age=63.3 years; age range=45-79 years) with a history of penicillin/cephalosporin allergy undergoing revision hip arthroplasty secondary to aseptic loosening or periprosthetic fractures. Serum vancomycin levels were measured (1) before administration of vancomycin, (2) at the time of skin incision, (3) every 1,5 hours thereafter until the end of the operation, (4) during the skin closure, and (5) after three and 12 hours from the initial dosage. Data regarding body weight, amounts of intraoperative blood loss, fluid and blood replacements and postoperative wound drainage were recorded. Results: The average blood loss, fluid replacement, and drain volume were 1280.3±575.8 (500-2700) mL, 2922.6±768.8 (1700-4600) mL, and 480.2±163.7 (200-850) mL, respectively. The mean levels of serum vancomycin were 46.3±21.8 (14.1-80.7) mg/L at the time of skin incision, 17.9±4.7 (9.4-30.9) and 9.8±2.2 (4.3-13.8) mg/L after 1.5 and 3 hours from the beginning of the surgery and 5.1±1.1 (2.9-6.8)mg/L after 12th hour postoperatively. The measured vancomycin levels were below the effective serum concentrations (< 5 mg/L) for 18 patients at 12 hours the administration of the first dose. A moderate level negative correlation between the blood loss/body weight ratio and vancomycin levels was found (p=0.004, r=-0.493). Predictive ROC curve analysis resulted in determining a blood loss volume higher than 1150 ml and a blood loss/body weight ratio higher than 18,5 is significant to estimate the vancomycin level below the minimum effective serum level at 12th hour postoperatively (AUC=0.793±0.16, p=0.009, AUC=0.753) 26±0.12, p=0.025, respectively). Conclusion: Evidence from this study has indicated vancomycin concentration at 12th hour is below the effective level in most patients. Thus, earlier repetitive infusion of vancomycin seems to be necessary in penicillin/cephalosporin-allergic patients undergoing revision hip arthroplasty, especially in those with high blood loss. Level of Evidence: Level III, Therapeutic Study Cite this article as: Çağlar Ö, Kaymakoğlu M, Çil A, Atilla B, Sarıcaoğlu F, Tokgözoğlu M. Vancomycin prophylaxis for revision hip arthroplasty in penicillin and cephalosporin sensitive patients: Is dose adjustment necessary in accordance with blood loss and fluid replacement? Acta Orthop Traumatol Turc 2021; 55(1): 53-6.
- 1 January 2021
- Published by AVES YAYINCILIK A.Ş. in Acta Orthopaedica et Traumatologica Turcica
- Vol. 55 (1) , 53-56
Open AccessVancomycin prophylaxis for revision hip arthroplasty in penicillin and cephalosporin sensitive patients: Is dose adjustment necessary in accordance with blood loss and fluid replacement?
Objective: The aims of this study were (1) to investigate the changes in the serum concentration of prophylactically administrated vancomycin in the perioperative period of revision hip arthroplasty in penicillin/cephalosporin-allergic patients, (2) to assess whether the postoperative re-administration of vancomycin is needed, and (3) to determine the relationships of vancomycin serum concentration with blood loss, body weight, and fluid replacement in such patients. Methods: This study consisted of 29 patients (20 females, 9 males; mean age=63.3 years; age range=45-79 years) with a history of penicillin/cephalosporin allergy undergoing revision hip arthroplasty secondary to aseptic loosening or periprosthetic fractures. Serum vancomycin levels were measured (1) before administration of vancomycin, (2) at the time of skin incision, (3) every 1,5 hours thereafter until the end of the operation, (4) during the skin closure, and (5) after three and 12 hours from the initial dosage. Data regarding body weight, amounts of intraoperative blood loss, fluid and blood replacements and postoperative wound drainage were recorded. Results: The average blood loss, fluid replacement, and drain volume were 1280.3±575.8 (500-2700) mL, 2922.6±768.8 (1700-4600) mL, and 480.2±163.7 (200-850) mL, respectively. The mean levels of serum vancomycin were 46.3±21.8 (14.1-80.7) mg/L at the time of skin incision, 17.9±4.7 (9.4-30.9) and 9.8±2.2 (4.3-13.8) mg/L after 1.5 and 3 hours from the beginning of the surgery and 5.1±1.1 (2.9-6.8)mg/L after 12th hour postoperatively. The measured vancomycin levels were below the effective serum concentrations (< 5 mg/L) for 18 patients at 12 hours the administration of the first dose. A moderate level negative correlation between the blood loss/body weight ratio and vancomycin levels was found (p=0.004, r=-0.493). Predictive ROC curve analysis resulted in determining a blood loss volume higher than 1150 ml and a blood loss/body weight ratio higher than 18,5 is significant to estimate the vancomycin level below the minimum effective serum level at 12th hour postoperatively (AUC=0.793±0.16, p=0.009, AUC=0.753) 26±0.12, p=0.025, respectively). Conclusion: Evidence from this study has indicated vancomycin concentration at 12th hour is below the effective level in most patients. Thus, earlier repetitive infusion of vancomycin seems to be necessary in penicillin/cephalosporin-allergic patients undergoing revision hip arthroplasty, especially in those with high blood loss. Level of Evidence: Level III, Therapeutic Study Cite this article as: Çağlar Ö, Kaymakoğlu M, Çil A, Atilla B, Sarıcaoğlu F, Tokgözoğlu M. Vancomycin prophylaxis for revision hip arthroplasty in penicillin and cephalosporin sensitive patients: Is dose adjustment necessary in accordance with blood loss and fluid replacement? Acta Orthop Traumatol Turc 2021; 55(1): 53-6.
- 1 February 2007
- Published by IMR Press in The Heart Surgery Forum
- Vol. 10 (1) , E36-E41
The Effects of Isoflurane, Sevoflurane, and Desflurane Anesthesia on Neurocognitive Outcome after Cardiac Surgery: A Pilot Study
Inhalation anesthetics such as isoflurane, sevoflurane, and desflurane are widely used in clinical practice; however, there is no study for comparing these drugs in cardiac surgery with respect to postoperative cognitive outcome and S100 beta protein (S100 BP) levels. In this study, we evaluated the effect of sevoflurane, isoflurane, and desflurane anesthesia on neuropsychological outcome and S100 BP levels in patients undergoing coronary artery bypass grafting (CABG) surgery with cardiopulmonary bypass (CPB). Forty-two male patients were prospectively randomized and classified into 3 groups according to the volatile agents used; isoflurane, sevoflurane, desflurane. All patients had a sufficient education level to participate in neuropsychological testing and a normal carotid Doppler ultrasonography. Blood samples for analysis of S100 BP were collected before anesthesia (T1), before heparinization (T2), 15 minutes into CPB (T3), following protamine administration (T4), postoperatively (T5), 24 hours after the operation (T6), postoperative day 3 (T7), and postoperative day 6 (T8). The neuropsychological tests, including Mini-Mental State Examination (MMSET) and visual-aural digit span test (VADST), were administered 1 day prior to surgery and on the third and sixth postoperative days. The postoperative third and sixth day MMSET scores and third day visual-written subtest scores in the sevoflurane group were significantly lower than in the isoflurane and desflurane groups (P < .05). S100 BP levels increased with the beginning of anesthesia in the sevoflurane and desflurane groups. Although S100 BP decreased to baseline levels on postoperative day 1 in the sevoflurane group, this was significantly higher on the third and sixth days postoperatively in the desflurane group (P < .05). In the isoflurane group, the S100 BP level was significantly higher than the baseline level only after CPB (P < .05). Our study suggests that isoflurane is associated with better neurocognitive functions than desflurane or sevoflurane after on-pump CABG. Sevoflurane seems to be associated with the worst cognitive outcome as assessed by neuropsychologic tests, and prolonged brain injury as detected by high S100 BP levels was seen with desflurane.
- 1 February 2007
- Published by IMR Press in The Heart Surgery Forum
- Vol. 10 (1) , E36-E41
The Effects of Isoflurane, Sevoflurane, and Desflurane Anesthesia on Neurocognitive Outcome after Cardiac Surgery: A Pilot Study
Inhalation anesthetics such as isoflurane, sevoflurane, and desflurane are widely used in clinical practice; however, there is no study for comparing these drugs in cardiac surgery with respect to postoperative cognitive outcome and S100 beta protein (S100 BP) levels. In this study, we evaluated the effect of sevoflurane, isoflurane, and desflurane anesthesia on neuropsychological outcome and S100 BP levels in patients undergoing coronary artery bypass grafting (CABG) surgery with cardiopulmonary bypass (CPB). Forty-two male patients were prospectively randomized and classified into 3 groups according to the volatile agents used; isoflurane, sevoflurane, desflurane. All patients had a sufficient education level to participate in neuropsychological testing and a normal carotid Doppler ultrasonography. Blood samples for analysis of S100 BP were collected before anesthesia (T1), before heparinization (T2), 15 minutes into CPB (T3), following protamine administration (T4), postoperatively (T5), 24 hours after the operation (T6), postoperative day 3 (T7), and postoperative day 6 (T8). The neuropsychological tests, including Mini-Mental State Examination (MMSET) and visual-aural digit span test (VADST), were administered 1 day prior to surgery and on the third and sixth postoperative days. The postoperative third and sixth day MMSET scores and third day visual-written subtest scores in the sevoflurane group were significantly lower than in the isoflurane and desflurane groups (P < .05). S100 BP levels increased with the beginning of anesthesia in the sevoflurane and desflurane groups. Although S100 BP decreased to baseline levels on postoperative day 1 in the sevoflurane group, this was significantly higher on the third and sixth days postoperatively in the desflurane group (P < .05). In the isoflurane group, the S100 BP level was significantly higher than the baseline level only after CPB (P < .05). Our study suggests that isoflurane is associated with better neurocognitive functions than desflurane or sevoflurane after on-pump CABG. Sevoflurane seems to be associated with the worst cognitive outcome as assessed by neuropsychologic tests, and prolonged brain injury as detected by high S100 BP levels was seen with desflurane.